Receptor activator of nuclear factor-κB ligand (RANKL) is a member of the tumor necrosis factor (TNF) superfamily and constitutes a key regulator in osteoclast development [8,9], inducing physiological and pathological bone resorption in osteolytic diseases, such as osteoporosis and arthritis [10]. The gene discussed is TNF; the disease is arthritic joint disease.